Clinical Research Services for Dermatology Ophthalmology Allergology Oral Care

Similar documents
Cosmetic Oils in comparison: penetration and occlusion of paraffin oil and vegetable oils

Sheffield Kidney Institute. Planning a Clinical Trial

INTENSIVE COURSE IN DERMATO-COSMETIC SCIENCES

Job Profile Clinical Research Associate III (CRA)

medical vision group

A PROVEN APPROACH to ACCELERATED CLINICAL DEVELOPMENT

A Second Opinion for Subjective Endpoints: The Case for an Endpoint Assessment Committee

Clinical Research Associate (CRA) - A Growing Career Path in Biotechnology / Pharmaceutical Industry

Regulatory requirements for Australia: Medicines, Cosmetics, Household Cleaning and Food Products RFA 2014

A clinical research organization

Guidance for Industry FDA Approval of New Cancer Treatment Uses for Marketed Drug and Biological Products

The 505(b)(2) Drug Development Pathway:

Inspections, Compliance, Enforcement, and Criminal Investigations

Advancing research: a physician s guide to clinical trials

Clinical Data for Medical Devices

EMA Clinical Laboratory Guidance - Key points and Clarifications PAUL STEWART

The FDA recently announced a significant

GLP vs GMP vs GCP Dominique Pifat, Ph.D., MBA The Biologics Consulting Group

Clinical Trials: Improving the Care of People Living With Cancer

Annex 7 Guidelines for the preparation of a contract research organization master file

Medical personnel are growing more aware of the extent of an esthetician s

Technology and Expertise Add Operational Value to Medical Device Trials

International Aloe Science Council Certified Facility and Products

C 5. chemical development contract research custom synthesis cgmp API manufacturing commercial production. Welcome to

BioWales 2015 Pharmaceutical Supply Chain Showcase. 04 March 2015

CHPA ASSOCIATE MEMBER Rx-to-OTC Switch Resource List

Overview. Health Science Authority. Implementation of ICH guideline in Singapore. Singapore s experience

General Wellness: Policy for Low Risk Devices. Draft Guidance for Industry and Food and Drug Administration Staff

INVITATION LETTER ASSIGNMENT TITLE: INDIVIDUAL CONSULTANCY SERVICES RELATED TO THE TRAINING ON ADVANCED GCP TRAINING FOR RBC/MRC.

Novartis Investigator Initiated Trials (IITs) Guidelines

QUALIFICATIONS PACK - OCCUPATIONAL STANDARDS FOR LIFE SCIENCES INDUSTRY OCCUPATION: RESEARCH AND DEVELOPMENT REFERENCE ID: LFS/Q0503

Abt Associates Inc. Abt Associates Clinical Trials Comprehensive clinical research services

Even we will get to use your product someday. Enough reason for us to deliver.

Responsibilities of Test Facility Management & Sponsor Rik Hendriks Werner Coussement

Applications of nanotechnology: Cosmetics

Clinical database/ecrf validation: effective processes and procedures

MicroSilver BG TM. The innovative agent for beautiful, healthy skin.

White paper: FDA Guidance for Industry Update Process Validation

Supplement to the Guidance for Electronic Data Capture in Clinical Trials

Guidance for Industry Computerized Systems Used in Clinical Investigations

We set things in motion and keep them moving. Metronomia Clinical Research Services

TEMPLATE DATA MANAGEMENT PLAN

clinical Trials - A Need for Organisational Change

SIB70110 Graduate Certificate in Intense Pulsed Light and Laser Hair Reduction

Guidance for Industry

Hollie Goddard Sr. IRB Coordinator McKesson Specialty Health

PAGE 1 PROJECT MANAGEMENT COMPETENCE CENTER SETTING MILESTONES PMCC CONSULTING

OVERVIEW OF CURRENT STATUS OF STEM CELL TRANSPLANTATION IN VIETNAM

Image Archiving for Digital Pathology

Revised checklist for BA/BE NOC effective from 01 st February 2014 (Draft for comments before 25 Jan 14)

The Concept of Quality in Clinical Research. Dorota Śwituła Senior Clinical Quality Assurance Advisor

Cosmetic products safety regulations

BEST PRACTICE FOR MAXIMUM TABLET QUALITY, AVOIDING THE FDA WARNING LETTER 483.

Nutraceutical Medical Research, LLC. By: Latesha Richards, Marketing Coordinator

Patient Handbook on Stem Cell Therapies

History and Principles of Good Clinical Practice

CRITERIA FOR ACCREDITING APPLIED SCIENCE PROGRAMS

Annex 7 Guidelines on pre-approval inspections

Joint Position on the Disclosure of Clinical Trial Information via Clinical Trial Registries and Databases 1 Updated November 10, 2009

Mayo Alliance for Clinical Trials

Advanced Performance and Responsibility Guidelines for the Nuclear Medicine Technologist. SUMMARY. Introduction 2

Statistical Operations: The Other Half of Good Statistical Practice

Hygiene License, Record-keeping Certificate & CIQ Labels for Imported Cosmetics in China

STAR Deutschland GmbH

CRITERIA FOR ACCREDITING APPLIED SCIENCE PROGRAMS

EHR (Electronic Health Record) based EDC for Clinical Trials and Quality Outcome in Eye Care. The new World of Clinical Research in Eye Care

YOuR SuppLIER for InnOvaTIvE and ERp-IndEpEndEnT finance SOLuTIOnS. perfection In detail.

Accelerating Clinical Trials Through Shared Access to Patient Records

Temple University - School of Pharmacy 425 Commerce Drive, Suite 175 Fort Washington, PA Phone: Fax:

Infoset builds software and services to advantage business operations and improve patient s life

The Clinical Trials Process an educated patient s guide

A Guide to Clinical Trials

Mayo Central Laboratory for Clinical Trials A Division within Mayo Clinical Trial Services

INDUSTRY OVERVIEW OVERVIEW OF HONG KONG ECONOMY. GDP, disposable income and consumption expenditure

Content Sheet 12-1: Overview of Personnel Management

Clinical Trial Logistics

SCIENTIFIC SUBSTANTIATION OF STANDARD OPERATIONAL PROCEDURES ROLE IN QUALITY ASSURANCE SYSTEM IN CLINICAL DRUG TRIALS

Competency Statements for Dental Public Health*

THE ACTIVITIES AND FUTURE DEVELOPMENT OF GCP INSPECTIONS IN TANZANIA

WHITE PAPER: ADAPTIVE CLINICAL TRIALS

PEOPLE > SCIENCE > SOLUTIONS

Full-time or part-time upto 1.0 FTE, 4 year fix term Principal Investigator Department of Cardiology Westmead Hospital

TALENT MANAGEMENT SOLUTIONS TO THE CRA SHORTAGE: Investing in a Global Talent Pool

SARS Expert Committee. Training on Public Health

Structure of State Regulatory Authorities REGISTRATION CERTIFICATE ISSUING AUTHORITY ROSZDRAVNADZOR

Agile Master Data Management TM : Data Governance in Action. A whitepaper by First San Francisco Partners

) UC 6:30 8:20 PM

FDA Guidance for Industry Update - Process Validation

Clinical trials in haemophilia

Hanover Center for Optical Technologies - HOT

11. Extension Potential Financial Benefits

EU ECOLABEL FOR ABSORBENT HYGIENE PRODUCTS

Clinical Trials. In Singapore. Clinical Trials in Asia Pacifi c. Introduction. Healthcare Clusters.

Presentation of second quarter 2010 results

2Technical Support 3Formulation Development 4Proof of Concept 5 GMP Services 6Advanced Drug Delivery 1EUDRAGIT Products Evonik. Power to create.

RBM as Competitive Advantage for Mid-sized CROs

Comparison Chart of FDA and EPA Good Laboratory Practice (GLP) Regulations and the OECD Principles of GLP

INTRODUCTION. This book offers a systematic, ten-step approach, from the decision to validate to

Managing Risk in Clinical Research. Dr Martha J Wrigley R&D Manager Senior Visiting Fellow University of Surrey

NATIONAL HEALTH COUNCIL RESOLUTION Nº 251, DATED 7 AUGUST 1997

Transcription:

Clinical Research Services for Dermatology Ophthalmology Allergology Oral Care About proderm Approach Service Study types Equipment Quality Consulting Site Management Publications

2 3 About proderm 2011 Establishment of Sensory Laboratory 86 95 75 2007 Incorporation of Oral Care Clinic Trusted Partner What started as a dermatological CRO in 1994 is today a clinical research service provider with an unmatched range of methodology, equipment and highly dedicated scientific experts. 50 43 2002 Start of Hair Care Laboratory 36 proderm was founded in 1994 by Klaus-P. Wilhelm, MD, Professor of Dermatology, a renowned specialist in dermatopharmacology and dermatotoxicology. 2000 Establishment of Deodorant and Antiperspirant Facilities With the motto 'Dedicated to Skin', the proderm research team has been dedicated since then, body and soul, to conducting clinical dermatological studies. 23 29 This clear focus has been expanded over the years by other core areas such as the indications of ophthalmology, oral hygiene and hair care. Nevertheless, 1997 Opening of Sun Protection Laboratory even after almost 20 years of work, proderm stands primarily for one thing: Continuity! 16 Continuous growth, continuous leadership, continuous independence - last but not least a continuously expanding scientific methods of highest quality. 1995 Implementation of Pharmaceutical Division 1994 Foundation of proderm # of employees: 4 # of studies p.a.: 40 5 Milestones No. of employees

4 5 Services Full Service From early phase consulting until archiving of study data - we are the professional, flexible, and trustworthy partner for your development project. proderm covers all aspects of a clinical trial. Thus, customers have the opportunity to individually define the type and scope of the desired service from our range of services. Cooperation usually starts with the development of an optimal study design and continues with obtaining the regulatory approval. After suitable patients or volunteers are recruited and the study is conducted in our clinical unit, the project is finalized by Data Management, Statistics and Medical Writing. Regardless of the type and scope of the project, with a total of 95 employees, we always assure that there is a substitute for all functions. With that we can react with high flexibility to the needs of our customers, even in times of high workload. a Consultancy a Regulatory Approval a Patient Recruitment a Project Management a Data Management a Statistics a Report Writing a Archiving

6 7 Approach Providing Professional Solutions Dedicated experts, innovative equipment and experience are the success ingredients of the professional solutions we offer for both individual and standard study objectives. We combine our passion for clinical research with our approach towards quality. For this reason, proderm stands not only for dedication, but also for professionalism, scientific methods and innovation. a Professional a Scientific a Innovative This is the foundation of our daily work, in which the needs of our customers take center stage. This is also our impetus for continuously striving for improvement. There are no differences made. Whether a top ten global player, a medium-sized enterprise or a startup, whether a standard test or an individual study design our principles are applied to all projects at all times.

8 9 Study types Safety & Tolerance Efficacy & Claim Support proderm conducts clinical phase I/IIa trials for pharmaceuticals, medical devices, cosmetics, food supplements and consumer products. In most cases, it is a matter of proving the tolerability or efficacy of topically applied products. Systemically acting products are also investigated as long as the primary target criteria are the effects on the skin or mucous membrane. With the proderm Pharma and proderm Cosmetics departments, proderm is embracing the fact that the regulatory environment and thus the conditions for a clinical trial vary greatly depending on the product to be tested. Under the direction of Dr. Reinhold Gahlmann, proderm Pharma investigates in predominantly monocentric trials: the local tolerability of topical medicines the bioequivalence of corticosteroids the efficacy of drugs or topical medical devices in proof-of-concept studies. At the same time, proderm Pharma has a network of qualified investigators in clinics and practices for multi-center studies. a Pharmaceuticals a Medical Devices a Cosmetics a Food Supplements a Consumer goods a Skin Care a Oral Care a Hair Care a Eye Care a Sun Protection a Intimate Hygiene Stefan Bielfeldt and his team in the proderm Cosmetics Division focus on the tolerability and proof of efficacy of cosmetics, food supplements and consumer products.

10 11 Equipment Experienced, Innovative, One of a Kind The multitude of innovative technologies (i.e. Raman Spectroscopy) and the extensive knowledge of our researchers to apply these techniques make us a one of a kind CRO. Our technical equipment goes far beyond known standards and is unique in the global CRO landscape. Thus, we are, for example, one of the few institutes that can offer the non-invasive technologies of confocal microscopy and Raman spectroscopy in combination. At the same time, we set benchmarks by our own developments. With our USR-CliP (Unit for Standardized and Reproducible Clinical Photography), we can, for example, achieve a high level of reproducibility and color fidelity in clinical photography. Our MacIS (Macroscopic Imaging System), on the other hand, allows unparalleled standardized macro photography. a 3D Scanners for Profilometry a In-vivo Confocal Microscopy a In-vivo Confocal Raman Spectroscopy a Clinical Photography a IR Thermography a Laser Perfusion Imaging a Radiometers a Videomicroscopy a UV Radiation Devices a Force Meters In our tests, we combine the various technologies in a validated environment and can thus present our sponsors with undreamt of solutions.

12 13 Quality Comprehensive Quality Management and ISO Certification Our service is of high quality, and we attach great importance to this. It is therefore not surprising that our quality management system goes far beyond the standards and we are the first German dermatological CRO to have received ISO certification. Compliance with ethical standards, current legal requirements and standards, the assurance of credible and valid data, reliable compliance with target dates and, last but not least, the continuous improvement of our products and services are aspects that we emphasize in our quality management system. Our system of standard operating procedures, quality control, qualification and training has proven itself in audits by customers and authorities, and is certified according to ISO 9001. a Quality Control a System Audits a Study Audits a Validation a Qualification a Training

14 15 Consulting 100 Years of Clinical Research Experience Make use of our problem-solving capabilities and go the right path from the very beginning. You are not going the way of the standards but are blazing a new trail with your product. Your innovative formulations require a pioneering spirit and scientific excellence of the clinical implementation. Your product offers properties that cannot be proven by conventional methods. Institute founder Prof. Dr. Klaus-P. Wilhelm and the senior consultant team with Dr. Reinhold Gahlmann, Stefan Bielfeldt and Dr. Dorothea Wilhelm will steer your project in the desired direction from the very start with their over 100 years of combined experience. In addition, you will be taken care of by experts who, with experience from more than 6,000 studies and over 30,000 examined products, will hold the steering wheel firmly in their hand and accompany you on your way with advice and action to solve even the greatest challenges. a Comprehensive publications a Comprehensive academic network a Close contacts to responsible authorities a Active in national and international working scientific groups and societies Because of our extensive inventory of technical equipment, you will benefit from a maximum of flexibility and methods developed explicitly for your project..

16 17 Site Management Publications Beyond Phase I: Hospitals and Dermatologic Offices Master the multicenter challenge with the proderm network of qualified investigators. The distinctive idea of service, the passion for clinical research, the demands for quality and professionalism - our test centers have been qualified in multiple ways in order to be included in our network of clinical testing facilities. As the primary responsible CRO, we will gladly support your project with this established network through and beyond phase I in the multicenter phases of development. Of course, the multicenter study can also be the start of our collaboration. Whether starting or continuing a successful cooperation, we assume the following tasks: Creating the test protocol Obtaining the regulatory approvals and ethics opinions Organization of the investigator's meeting Training & evaluator calibration Site initiation Monitoring Data management Statistics Report writing Extract of recent Publications Bielfeldt S, Röck C and Wilhelm KP, Chances and limits of an improved method to assess water resistance of cosmetic sunscreen products in vitro on polymethylmethacrylate plates. Int J Cosmet Sci: 1-5, 2012. Bielfeldt S, Henss R, Koop U, Degwert J, Heinrich U, Jassoy C, Meyer J, Tronnier H, Jentzsch A and Blume G, Internet-based lay person rating of facial photographs to assess effects of a cleansing product and a decent cosmetic foundation on the attractiveness of female faces. Int J Cosmet Sci: 1-5,2012. Wilhelm D, Himmelmann A, Axmann E-M, Wilhelm K-P, Clinical efficacy of a new tooth and tongue gel applied with a tongue cleaner in reducing oral halitosis, Quintessence Int, 43:709 718, 2012 Daehnhardt-Pfeiffer S, Surber C, Wilhelm K-P, Daehnhardt D, Springmann G, Boettcher M, Foelster-Holst R, Noninvasive stratum corneum sampling and electron microscopical examination of skin barrier integrity: pilot study with a topical glycerin formulation for atopic dermatitis, Skin Pharmacol Physiol 25, 155, 2012. Steiling W, Buttgereit P, Hall B, O'Keeffe L, Safford B, Tozer S and Coroama M, Skin exposure to deodorants/antiperspirants in aerosol form. Food Chem Toxicol, 50: 2206-2215, 2012. Bielfeldt S, Böhling A and Wilhelm K-P, Bioengineering methods to assess aging parameters in the depth of the skin. SOFW Journal, 137: 2-9, 2011.

proderm Institute for Applied Dermatological Research GmbH Kiebitzweg 2 22869 Schenefeld/Hamburg Tel: +49-40-839 358-0 Fax: +49-40-839 358-39 www.proderm.de